Pregledni rad

END-STAGE RENAL DISEASE IN ELDERLY

PETAR KES ; Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju, klinika za unutarnje bolesti, Klinički bolnički centar Zagreb, Zagreb, Hrvatska
NIKOLINA BAŠIĆ JUKIĆ ; Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju, klinika za unutarnje bolesti, Klinički bolnički centar Zagreb, Zagreb, Hrvatska
IVANA JURIĆ ; Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju, klinika za unutarnje bolesti, Klinički bolnički centar Zagreb, Zagreb, Hrvatska
BRUNETTA GAVRANIĆ ; Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju, klinika za unutarnje bolesti, Klinički bolnički centar Zagreb, Zagreb, Hrvatska

Sažetak

The balance and quality of different renal replacement treatment modalities used in the elderly with end-stage renal disease vary between countries depending on economic resources, distribution of renal units, number of specialists, and patterns of reimbursement of
both hospitals and physicians. elderly patients with end-stage renal disease need detailed assessment of medical, psychological, motor, and social factors in order to choose an appropriate renal replacement treatment option. Presence or absence of significant comorbidity is much more important than the chronological age. the choice between hemodialysis and continuous ambulatory peritoneal dialysis is largely dependant on preferences of the local team and the patient. Patients with adequate cardiovascular systems are generally considered to be more suitable for hemodialysis. Hemoglobin should be optimized (Hb between 100 and 120 g/L) in all patients. Poor cardiac status and/or angina will require assessment, medical treatment, and, if necessary, surgical treatment or angioplasty. Transplantation should be considered in all reasonably fit and carefully selected patients older than 65 or even 70 years. only the permanent shortage of suitable kidneys limits our ability to treat all those who could benefit from this type of treatment. renal transplant recipients may benefit in terms of both survival and quality of life even if older than 70 years and beyond. immunosuppressive therapy in elderly patients should be moderate.

Ključne riječi

elderly; chronic renal failure; end-stage renal disease; dialysis; kidney transplantation

Hrčak ID:

99535

URI

https://hrcak.srce.hr/99535

Datum izdavanja:

3.4.2013.

Podaci na drugim jezicima: hrvatski

Posjeta: 22.183 *